← FDA Drug Approvals (Drugs@FDA)
OCTREOTIDE ACETATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: TEVA PHARMS USA INC · Approved 2023-12-05
Drug application
- FDA Application #
ANDA210317- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OCTREOTIDE ACETATE
- Generic name
- OCTREOTIDE ACETATE
- Active ingredients
- OCTREOTIDE ACETATE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- TEVA PHARMS USA INC
- Manufacturer
- Teva Pharmaceuticals, Inc.
- First approval
- 2023-12-05
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown